Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana 46202


Purpose:

The purpose of this study is to determine if haplotype-mismatched HSCT is associated with an improvement in treatment-related mortality (TRM) rate at 6 months.


Criteria:

Inclusion Criteria: - Patients must have histologically documented AML, ALL, MDS, CML, Acute myeloid leukemia (AML) with one or more of the following criteria - CR 1 with poor risk features - CR 2, or higher order CR - Acute lymphoblastic leukemia (ALL) with one of the following criteria - CR 1 with poor risk features - CR 2, or higher order CR - Myelodysplasia, RAEB I - Donor has been identified - Age ≤ 65 years. - Performance Status 0-1. Exclusion Criteria: - Patients relapsing <6 months after autologous SCT are not eligible. - Patients with active infections requiring oral or intravenous antibiotics are not eligible for enrollment until resolution of infection. - Non-pregnant and non-nursing


NCT ID:

NCT00593554


Primary Contact:

Principal Investigator
Sherif Farag, MD/PhD
Indiana University School of Medicine


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana 46202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.